# Bristol-Myers Squibb Raises 2026 Revenue Guidance After Q3 Beat By John Kim Canonical URL: https://www.tokenpost.com/news/business/43485 Published: 2026-10-29T11:59:46.000Z Updated: 2026-10-29T11:59:46.000Z Section: Business > Third-quarter revenue rose 7.2% year over year to $13.1 billion, and non-GAAP earnings per share reached $1.35. Bristol-Myers Squibb raised its 2026 revenue guidance after third-quarter revenue and non-GAAP earnings per share exceeded estimates. Revenue reached $13.1 billion, up 7.2% from a year earlier. Revenue topped estimates by $370 million. Non-GAAP earnings per share was $1.35, beating estimates by 13 cents. Both results topped estimates in an earlier [quarter preview](), which projected revenue of $12.73 billion and earnings per share of $1.22. For 2026, Bristol-Myers Squibb set a revenue range of $49.75 billion to $50.25 billion and a non-GAAP earnings-per-share range of $6.35 to $6.55. The EPS range includes a negative $0.60-per-share net impact from acquired in-process research and development charges and licensing income. ## Links in this article - [quarter preview](https://www.tokenpost.com/news/business/42951)